Cargando…

YOD1 serves as a potential prognostic biomarker for pancreatic cancer

BACKGROUND: Ubiquitination is a basic post-translational modification of intracellular proteins and can be reversed enzymatically by DUBs (deubiquitinating enzymes). More than 90 DUBs have been identified. Among them, the deubiquitinating enzyme YOD1, a member of the ovarian tumor domain protease (O...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhishuo, Zhao, Wenxia, Li, Yiming, Li, Yang, Cheng, Hanzeng, Zheng, Liyun, Sun, Xiaoyu, Liu, Hao, Shao, Rongguang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Primary Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9158148/ https://www.ncbi.nlm.nih.gov/pubmed/35642058 http://dx.doi.org/10.1186/s12935-022-02616-9

Ejemplares similares

SCUBE3 serves as an independent poor prognostic factor in breast cancer
por: Huo, Qin, et al.
Publicado: (2021)

Pre-treatment prognostic nutritional index may serve as a potential biomarker in urinary cancers: a systematic review and meta-analysis
por: Qi, Feng, et al.
Publicado: (2018)

CircADARB1 serves as a new biomarker in natural killer T-cell lymphoma and a potential regulator of p-Stat3
por: Mei, Mei, et al.
Publicado: (2021)

Hsa_circ_0004831 serves as a blood-based prognostic biomarker for colorectal cancer and its potentially circRNA-miRNA-mRNA regulatory network construction
por: Xing, Linlin, et al.
Publicado: (2020)

SNAP25 is a potential prognostic biomarker for prostate cancer
por: Di, Longjiang, et al.
Publicado: (2022)

NAT10 as a potential prognostic biomarker and therapeutic target for HNSCC
por: Tao, Wenjie, et al.
Publicado: (2021)

Bioinformatics analysis combined with experiments to explore potential prognostic factors for pancreatic cancer
por: Ke, Mu-jing, et al.
Publicado: (2020)

CPNE1 is a potential prognostic biomarker, associated with immune infiltrates and promotes progression of hepatocellular carcinoma
por: Su, Jinfang, et al.
Publicado: (2022)

NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
por: Zhao, Cui, et al.
Publicado: (2021)

Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for hepatocellular carcinoma
por: Long, Junyu, et al.
Publicado: (2019)

MiR-99a may serve as a potential oncogene in pediatric myeloid leukemia
por: Zhang, Lidan, et al.
Publicado: (2013)

CLEC3B as a potential diagnostic and prognostic biomarker in lung cancer and association with the immune microenvironment
por: Sun, Jiaxing, et al.
Publicado: (2020)

Overexpression of kinesin superfamily members as prognostic biomarkers of breast cancer
por: Li, Tian-Fu, et al.
Publicado: (2020)

The plasma exosomal miR-1180-3p serves as a novel potential diagnostic marker for cutaneous melanoma
por: Guo, Yeye, et al.
Publicado: (2021)

Deubiquitinase YOD1: the potent activator of YAP in hepatomegaly and liver cancer
por: Kim, Youngeun, et al.
Publicado: (2017)

Synergistic effect of YOD1 and USP21 on the Hippo signaling pathway
por: Park, Sang-Soo, et al.
Publicado: (2023)

ITGA3 serves as a diagnostic and prognostic biomarker for pancreatic cancer
por: Jiao, Yan, et al.
Publicado: (2019)

Construction of a prognostic model with histone modification-related genes and identification of potential drugs in pancreatic cancer
por: Chen, Yuan, et al.
Publicado: (2021)

H/ACA box small nucleolar RNA 7B acts as an oncogene and a potential prognostic biomarker in breast cancer
por: Sun, Yihan, et al.
Publicado: (2019)

THE DIMENSIONS OF YOUNG ONSET DEMENTIA (YOD) AND WHAT THESE MEAN FOR EXTENDED WORKING LIVES
por: Taylor, Philip
Publicado: (2022)

Identification of potential biomarkers and candidate small molecule drugs in glioblastoma
por: Lu, Wei-cheng, et al.
Publicado: (2020)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

A four-DNA methylation signature as a novel prognostic biomarker for survival of patients with gastric cancer
por: Li, Chunmei, et al.
Publicado: (2020)

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer
por: Xie, Qin, et al.
Publicado: (2020)

Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma
por: Bian, Tingting, et al.
Publicado: (2021)

A potential prognostic prediction model of colon adenocarcinoma with recurrence based on prognostic lncRNA signatures
por: Jin, Lipeng, et al.
Publicado: (2020)

UGT1A Gene Family Members Serve as Potential Targets and Prognostic Biomarkers for Pancreatic Cancer
por: Feng, Lei, et al.
Publicado: (2021)

FOXC2 is a prognostic biomarker and contributes to the growth and invasion of human hepatocellular carcinoma
por: Chen, Jinzhang, et al.
Publicado: (2020)

TEADs serve as potential prognostic biomarkers and targets for human gastric cancer
por: Wang, Meng-huan, et al.
Publicado: (2022)

Laparoscopic spleen-preserving hilar lymph node dissection through pre-pancreatic and retro-pancreatic approach in patients with gastric cancer
por: Zheng, Liansheng, et al.
Publicado: (2016)

Biomarker implication of kallikrein-related peptidases as prognostic tissue substrates of poor survival in colorectal cancer
por: Peng, Qiliang, et al.
Publicado: (2020)

LRRK2 is a candidate prognostic biomarker for clear cell renal cell carcinoma
por: Yang, Chunxiu, et al.
Publicado: (2021)

Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
por: Gao, Lingling, et al.
Publicado: (2020)

Cytochrome b561 Serves as a Potential Prognostic Biomarker and Target for Breast Cancer
por: Yang, Xiaochen, et al.
Publicado: (2021)

Integrin-β6 Serves as a Potential Prognostic Serum Biomarker for Gastric Cancer
por: Li, Zequn, et al.
Publicado: (2021)

A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease
por: Miao, Liu, et al.
Publicado: (2019)

Analyzing the lncRNA, miRNA, and mRNA-associated ceRNA networks to reveal potential prognostic biomarkers for glioblastoma multiforme
por: Zhu, Xiaolong, et al.
Publicado: (2020)

Blockade of deubiquitinase YOD1 degrades oncogenic PML/RARα and eradicates acute promyelocytic leukemia cells
por: Shao, Xuejing, et al.
Publicado: (2022)

Circulating Monocytes Serve as Novel Prognostic Biomarker in Pancreatic Ductal Adenocarcinoma Patients
por: Hansen, Frederik J., et al.
Publicado: (2023)

IMUP and GPRC5A: two newly identified risk score indicators in pancreatic ductal adenocarcinoma
por: Wei, Rong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qk59mcd7v0g18derr85v568mua